This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2014 results on Thursday, October 23, 2014, before the...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today unveiled its new, state-of-the-art clinical test laboratory in Marlborough, Massachusetts with...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, will host Investor Day for institutional investors and financial analysts...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Franklin R. Cockerill, III, M.D., has joined the company as vice president and...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today celebrates a decade on the North America Dow Jones Sustainability Index (DJSI) and 11...
The percentage of positive drug tests among American workers has increased for the first time in more than a decade, fueled by a rise in marijuana and amphetamines, according to an analysis of 8.5...
A growing number of patients in the United States are being tested – and testing positive – for the mosquito-borne chikungunya virus, according to a study presented at the Interscience...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share,...
Revenues from continuing operations of $1.9 billion, up 4.8% versus prior year Adjusted diluted EPS from continuing operations of $1.08, up 1.9% versus prior year Reported diluted EPS from...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Vicky Gregg to serve as a director, effective...
Five states that have implemented multi-faceted prescription drug abuse prevention programs in recent years showed the highest rate of decline in prescription drug misuse rates nationwide,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2014 results on Thursday, July 24, 2014, before the...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new cancer test service based on the FDA-approved THxID®-BRAF test from...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman Sachs 35th Annual Global...
Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 39th Annual Heath Care...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that several scientists from its Athena Diagnostics specialty neurology business...
Full year revenue and adjusted earnings per diluted share guidance unchanged First quarter adjusted diluted EPS from continuing operations of $0.84, vs. $0.89 in 2013 First quarter adjusted...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Steward Health Care System LLC (Steward), New England's largest community-based accountable care...
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, has signed a definitive agreement to manage the clinical testing laboratory at Charlotte Hungerford Hospital, a general acute care hospital in Torrington, Connecticut.
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a suite of new testing services from its Athena Diagnostics specialty neurology...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, has completed the previously announced acquisition of Summit Health, a leading provider of on-site...
For the first time, Americans nationwide can directly access their personal laboratory data through Quest Diagnostics (NYSE: DGX), the world's leading...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2014...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information and services, today announced that its Focus...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it intends to offer...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed the previously...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced new pathology and blood test...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will exhibit at booth 3064 and host a series of "Tech...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced a series of senior leadership...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
ChartMaxx, the enterprise content management (ECM) solution from Quest Diagnostics (NYSE:DGX), has achieved 2014 Edition Modular EHR*...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise...
Approximately one in two patients with atrial fibrillation (Afib) do not optimally reduce their risk of stroke or bleeding when treated with the most...
A final rule issued today by the U.S. Department of Health and Human Services (HHS) giving Americans increased access to their personal health...
Fourth quarter adjusted diluted EPS from continuing operations of $1.03, 2% above prior year Fourth quarter reported diluted EPS from continuing...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and the University of California, San...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today updated its estimates for full-year 2013 revenues...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that BRCAvantage™, a service-rich oncology...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
Drug use among American workers declined dramatically over the past 25 years, although the rate of positive test results for certain drugs, including...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
Adjusted diluted EPS from continuing operations of $1.02, vs. $1.15 in 2012 Reported diluted EPS from continuing operations of $2.66, vs. $0.98 in 2012...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of BRCAvantage™,...
According to the results of a recent Quest Diagnostics (NYSE: DGX) survey, seventy-two percent (72 percent) of American women age 18 and older have...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today provided a preview of revenues and earnings per...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has acquired...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, has again been named to the Dow Jones Sustainability...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2013 results on
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that on September 30, 2013...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Care360 cloud-based...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of a new lab-developed...
Students at Harvard, Massachusetts Institute of Technology and Brown University, Massachusetts Asian & Pacific Islanders (MAP) for Health and local employee...
Quest Diagnostics (NYSE: DGX) and the New York Giants are teaming up to find new ways to use laboratory diagnostic information services to...
Adjusted diluted EPS from continuing operations of $1.06, vs. $1.15 in 2012 Reported diluted EPS from continuing operations of $0.99, vs. $1.09 in 2012...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has...
Quest Diagnostics Incorporated (NYSE: DGX) today announced that Mark J. Guinan will join the company on July 29 as its next Senior Vice President...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a collaboration with the U.S. Centers...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2013...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced an agreement with AT&T* to provide the...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Steve Rusckowski, President...
Quest Diagnostics (NYSE: DGX), the world's leading diagnostic information services company, and Hologic, Inc. (Hologic) (NASDAQ:...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Steve Rusckowski, President...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has acquired the toxicology and...
Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
Adjusted diluted EPS from continuing operations of $0.89, vs. $1.05 in 2012 Reported diluted EPS from continuing operations of $0.72, vs. $0.97 in...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has entered...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, announced today that Jim Davis, a former vice...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed the sale of its...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of two new blood tests...
Individuals who use marijuana recreationally are more likely to misuse other drugs, including pain-controlling, but potentially addictive narcotics,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2013...
Despite increased public attention on the epidemic of prescription medication abuse, about three in five Americans tested misused their prescription...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Sukumar Nagendran, M.D., has...
A new test based on gene sequencing may be used to assess a patient's suitability for treatment with CCR5 antagonists, a class of HIV antiretroviral...
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability...
On World Kidney Day, Quest Diagnostics, the world's leading provider of diagnostic information services, today announced its support of the updated...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that Robert A. Hagemann, Senior Vice...
Job candidates subject to pre-employment drug screening tested positive for illicit drugs at a greater rate in the first six months of 2012 than in...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, is presenting its award-winning healthcare information...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that that it has been recognized in...
In line with its reputation for being on the forefront of tools that provide insights for better healthcare, Quest Diagnostics (NYSE:DGX), the world's...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive...